Recursion Pharmaceuticals (RXRX) Earnings Date, Estimates & Call Transcripts $6.53 +0.13 (+2.03%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recursion Pharmaceuticals Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 25Before Market OpensEstimatedActual EPS (Nov. 6) -$0.34 Missed By -$0.01 Consensus EPS (Nov. 6) -$0.33 Recursion Pharmaceuticals released Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.34, which missed analysts' consensus estimates of -$0.33 by $0.01. Quarterly revenue rose 147.6% year-over-year to $26.08 million, above analyst estimates of $12.62 million. With a trailing EPS of -$1.53, Recursion Pharmaceuticals' earnings are expected to grow next year, from ($1.56) to ($1.40) per share. SEC 10-Q/10-K FilingRXRX Upcoming EarningsRecursion Pharmaceuticals' next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules. Get Recursion Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Recursion Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRXRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RXRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Recursion Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($1.56) EPSNext Year EPS Consensus Estimate: ($1.40) EPS Recursion Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/25/2025(Estimated)-------11/6/2024Q3 2024-$0.33-$0.34 -$0.01-$0.34$12.62M$26.08M8/8/2024Q2 2024-$0.35-$0.40 -$0.05-$0.40$11.96M$14.42M5/9/2024Q1 2024-$0.43-$0.39+$0.04-$0.39$11.10M$13.80M2/27/2024Q4 2023-$0.46-$0.40+$0.06-$0.40$12.37M$10.89M11/9/2023Q3 2023-$0.38-$0.43 -$0.05-$0.43$12.20M$10.53M8/8/2023Q2 2023-$0.38-$0.38--$0.38$10.43M$11.02M5/8/2023Q1 2023-$0.35-$0.34+$0.01-$0.34$15.93M$12.13M2/27/2023Q4 2022-$0.15-$0.31 -$0.16-$0.31$66.68M$13.68M Recursion Pharmaceuticals Earnings - Frequently Asked Questions When is Recursion Pharmaceuticals's earnings date? Recursion Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on RXRX's earnings history. Did Recursion Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Recursion Pharmaceuticals (NASDAQ:RXRX) missed the analysts' consensus estimate of ($0.33) by $0.01 with a reported earnings per share (EPS) of ($0.34). Learn more on analysts' earnings estimate vs. RXRX's actual earnings. How can I view Recursion Pharmaceuticals's earnings report? Recursion Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded annual revenue of $44.58 million. How much profit does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded net income of -$328.07 million. RXRX has generated -$1.53 earnings per share over the last four quarters. What is Recursion Pharmaceuticals's EPS forecast for next year? Recursion Pharmaceuticals's earnings are expected to grow from ($1.56) per share to ($1.40) per share in the next year. More Earnings Resources from MarketBeat Related Companies ROIV Earnings Date ASND Earnings Date BPMC Earnings Date RVMD Earnings Date BBIO Earnings Date LNTH Earnings Date LEGN Earnings Date ELAN Earnings Date CYTK Earnings Date NUVL Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:RXRX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXRX Stock Alerts